Eikon Therapeutics, Inc. (NASDAQ:EIKN) IPO
IPO
Priced at US$18.00 a share on Feb 4, 2026.
- Price
- US$18.00 a share
- Shares offered
- 21,177,600 shares of common stock
- Offering size
- US$381.2 million
- Underwriters' option
- Up to 3,176,640 more shares
- Listing
- EIKN on the Nasdaq Global Select Market
- Underwriters
- J.P. Morgan, Morgan Stanley, BofA Securities, Cantor, Mizuho · In the order on the cover
- Shares delivered
- On or about Feb 6, 2026
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | May 9, 2025 |
| Filed publicly | Jan 9, 2026 |
| Amended once | Jan 28, 2026 |
| Shares registered with an exchange | Jan 28, 2026 |
| Declared effective by the SEC | Jan 30, 2026 |
| Final prospectus, with the price | Feb 5, 2026 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Feb 5, 2026 |
| S-1MEF · Registration of more shares for the same offering | Feb 4, 2026 |
| CERT · Exchange's certificate of listing | Feb 4, 2026 |
| EFFECT · Notice that a registration is effective | Jan 30, 2026 |
| 8-A12B · Registration of shares for listing on an exchange | Jan 28, 2026 |
| S-1/A · Registration statement, amended | Jan 28, 2026 |
| S-1 · Registration statement | Jan 9, 2026 |
| DRS/A · Draft registration statement, amended | Dec 12, 2025 |
| DRS/A · Draft registration statement, amended | Sep 26, 2025 |
| DRS/A · Draft registration statement, amended | Jul 1, 2025 |
| DRS · Draft registration statement | May 9, 2025 |
From the cover of the final prospectus (424B4) filed Feb 5, 2026